81 related articles for article (PubMed ID: 25031041)
1. Perspectives on a combined test of multi serum biomarkers in China: towards screening for and diagnosing hepatocellular carcinoma at an earlier stage.
Zhang K; Song P; Gao J; Li G; Zhao X; Zhang S
Drug Discov Ther; 2014 Jun; 8(3):102-9. PubMed ID: 25031041
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of midkine as a diagnostic serum biomarker in hepatocellular carcinoma.
Zhu WW; Guo JJ; Guo L; Jia HL; Zhu M; Zhang JB; Loffredo CA; Forgues M; Huang H; Xing XJ; Ren N; Dong QZ; Zhou HJ; Ren ZG; Zhao NQ; Wang XW; Tang ZY; Qin LX; Ye QH
Clin Cancer Res; 2013 Jul; 19(14):3944-54. PubMed ID: 23719264
[TBL] [Abstract][Full Text] [Related]
3. Midkine (MDK) in Hepatocellular Carcinoma: More than a Biomarker.
Christou C; Stylianou A; Gkretsi V
Cells; 2024 Jan; 13(2):. PubMed ID: 38247828
[TBL] [Abstract][Full Text] [Related]
4. Mass spectrometry based biomarkers for early detection of HCC using a glycoproteomic approach.
Mechref Y; Peng W; Gautam S; Ahmadi P; Lin Y; Zhu J; Zhang J; Liu S; Singal AG; Parikh ND; Lubman DM
Adv Cancer Res; 2023; 157():23-56. PubMed ID: 36725111
[TBL] [Abstract][Full Text] [Related]
5. Risk stratification and early detection biomarkers for precision HCC screening.
Lee YT; Fujiwara N; Yang JD; Hoshida Y
Hepatology; 2023 Jul; 78(1):319-362. PubMed ID: 36082510
[TBL] [Abstract][Full Text] [Related]
6. Blood-Based Biomarkers for HCC Surveillance: Ready for the Center Stage?
Singal AG; Yang JD; Parikh ND
Am J Gastroenterol; 2023 Oct; ():. PubMed ID: 37795908
[No Abstract] [Full Text] [Related]
7. Novel biomarkers and strategies for HCC diagnosis and care.
Wang AE; Leven EA; Grinspan LT; Villanueva A
Clin Liver Dis (Hoboken); 2024; 23(1):e0152. PubMed ID: 38707238
[No Abstract] [Full Text] [Related]
8. Hepatocellular carcinoma tumour markers: current role and expectations.
Rich N; Singal AG
Best Pract Res Clin Gastroenterol; 2014 Oct; 28(5):843-53. PubMed ID: 25260312
[TBL] [Abstract][Full Text] [Related]
9. Clinical utility of simultaneous measurement of alpha-fetoprotein and des-γ-carboxy prothrombin for diagnosis of patients with hepatocellular carcinoma in China: A multi-center case-controlled study of 1,153 subjects.
Song P; Feng X; Inagaki Y; Song T; Zhang K; Wang Z; Zheng S; Ma K; Li Q; Kong D; Wu Q; Zhang T; Zhao X; Hasegawa K; Sugawara Y; Kokudo N; Tang W;
Biosci Trends; 2014 Oct; 8(5):266-73. PubMed ID: 25382443
[TBL] [Abstract][Full Text] [Related]
10. Diagnostic Performance of Des-γ-carboxy Prothrombin for Hepatocellular Carcinoma: A Meta-Analysis.
Zhu R; Yang J; Xu L; Dai W; Wang F; Shen M; Zhang Y; Zhang H; Chen K; Cheng P; Wang C; Zheng Y; Li J; Lu J; Zhou Y; Wu D; Guo C
Gastroenterol Res Pract; 2014; 2014():529314. PubMed ID: 25165471
[TBL] [Abstract][Full Text] [Related]
11. Biomarkers: evaluation of clinical utility in surveillance and early diagnosis for hepatocellular carcinoma.
Song P; Tang Q; Feng X; Tang W
Scand J Clin Lab Invest Suppl; 2016; 245():S70-6. PubMed ID: 27438343
[TBL] [Abstract][Full Text] [Related]
12. Current Status and Perspective Biomarkers in AFP Negative HCC: Towards Screening for and Diagnosing Hepatocellular Carcinoma at an Earlier Stage.
Luo P; Wu S; Yu Y; Ming X; Li S; Zuo X; Tu J
Pathol Oncol Res; 2020 Apr; 26(2):599-603. PubMed ID: 30661224
[TBL] [Abstract][Full Text] [Related]
13. Development of a Reliable GADSAH Model for Differentiating AFP-negative Hepatic Benign and Malignant Occupying Lesions.
Long X; Zeng H; Zhang Y; Lu Q; Cao Z; Shu H
J Hepatocell Carcinoma; 2024; 11():607-618. PubMed ID: 38549786
[TBL] [Abstract][Full Text] [Related]
14. The potential of CircRNA1002 as a biomarker in hepatitis B virus-related hepatocellular carcinoma.
Li Y; Li R; Cheng D; Fu X; Fu L; Peng S
PeerJ; 2022; 10():e13640. PubMed ID: 35782101
[TBL] [Abstract][Full Text] [Related]
15. The Oncogenic and Diagnostic Potential of Stanniocalcin 2 in Hepatocellular Carcinoma.
Wu Z; Cheng H; Liu J; Zhang S; Zhang M; Liu F; Li Y; Huang Q; Jiang Y; Chen S; Lv L; Li D; Zeng JZ
J Hepatocell Carcinoma; 2022; 9():141-155. PubMed ID: 35300206
[TBL] [Abstract][Full Text] [Related]
16. Search for Effective Serum Tumor Markers for Early Diagnosis of Hepatocellular Carcinoma Associated with Hepatitis C.
Malov SI; Malov IV; Kuvshinov AG; Marche PN; Decaens T; Macek-Jilkova Z; Yushchuk ND
Sovrem Tekhnologii Med; 2021; 13(1):27-33. PubMed ID: 34513063
[TBL] [Abstract][Full Text] [Related]
17. MicroRNA‑223‑induced inhibition of the
Liu Z; Ma T; Duan J; Liu X; Liu L
Mol Med Rep; 2021 Feb; 23(2):. PubMed ID: 33355365
[TBL] [Abstract][Full Text] [Related]
18. Advances in the early diagnosis of hepatocellular carcinoma.
Wang W; Wei C
Genes Dis; 2020 Sep; 7(3):308-319. PubMed ID: 32884985
[TBL] [Abstract][Full Text] [Related]
19. Bioinformatics analysis of molecular genetic targets and key pathways for hepatocellular carcinoma.
Tu J; Chen J; He M; Tong H; Liu H; Zhou B; Liao Y; Wang Z
Onco Targets Ther; 2019; 12():5153-5162. PubMed ID: 31303768
[TBL] [Abstract][Full Text] [Related]
20. MicroRNA-203 impacts on the growth, aggressiveness and prognosis of hepatocellular carcinoma by targeting
Simile MM; Peitta G; Tomasi ML; Brozzetti S; Feo CF; Porcu A; Cigliano A; Calvisi DF; Feo F; Pascale RM
Oncotarget; 2019 Apr; 10(29):2835-2854. PubMed ID: 31073374
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
